Adriamycin cardiotoxicity and calcium entry blockers: the need for caution in the combination.
D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D004317:Doxorubicin / Q000627:therapeutic use / Q000633:toxicity*; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008929:Mitochondria, Heart / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000166:cytology / Q000201:enzymology; D013481:Superoxides / Q000378:metabolism / Q000494:pharmacology
D002121:Calcium Channel Blockers; D013481:Superoxides; D004317:Doxorubicin; D002118:Calcium